Mira Pharmaceuticals Files 8-K: Other Event
Ticker: MIRA · Form: 8-K · Filed: Oct 23, 2025 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Oct 23, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Mira Pharma filed an 8-K for an 'Other Event' on 10/23/25. Details TBD.
AI Summary
Mira Pharmaceuticals, Inc. filed an 8-K on October 23, 2025, reporting an "Other Event." The filing does not contain specific details about the event, its financial implications, or any associated dates beyond the filing date itself. The company's principal executive offices are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida.
Why It Matters
This 8-K filing indicates a significant event has occurred for Mira Pharmaceuticals, Inc., requiring public disclosure, though the nature of the event is not specified in the provided text.
Risk Assessment
Risk Level: medium — The filing is an 8-K for an 'Other Event' without specific details, creating uncertainty about the nature and impact of the event.
Key Players & Entities
- MIRA PHARMACEUTICALS, INC. (company) — Registrant
- October 23, 2025 (date) — Date of earliest event reported
- 1200 Brickell Avenue, Suite 1950 #1183 Miami, Florida 33131 (address) — Principal Executive Offices
- Mira1a Therapeutics, Inc. (company) — Former Company Name
- 20220112 (date) — Date of Former Company Name Change
FAQ
What specific event is Mira Pharmaceuticals, Inc. reporting in this 8-K filing?
The provided text of the 8-K filing states it is for an 'Other Event' but does not specify the nature of this event.
What is the filing date of this 8-K report?
The filing date, and the date of the earliest event reported, is October 23, 2025.
Where are Mira Pharmaceuticals, Inc.'s principal executive offices located?
The principal executive offices are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
What was the former name of Mira Pharmaceuticals, Inc.?
The former name of the company was Mira1a Therapeutics, Inc.
When did the company change its name from Mira1a Therapeutics, Inc.?
The date of the name change was January 12, 2022 (20220112).
Filing Stats: 811 words · 3 min read · ~3 pages · Grade level 16.3 · Accepted 2025-10-23 16:01:34
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share MIRA The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 38KB
- 0001493152-25-019065.txt ( ) — 203KB
- mira-20251023.xsd (EX-101.SCH) — 3KB
- mira-20251023_lab.xml (EX-101.LAB) — 33KB
- mira-20251023_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIRA PHARMACEUTICALS, INC. Dated: October 23, 2025 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer